SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-023649
Filing Date
2020-05-08
Accepted
2020-05-08 17:08:56
Documents
5
Period of Report
2020-06-22
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A etnb-def14a_20200622.htm DEF 14A 613481
2 GRAPHIC gz4ktxm0veew000002.jpg GRAPHIC 2321
3 GRAPHIC gz4ktxm0veew000003.jpg GRAPHIC 47730
4 GRAPHIC gz4ktxm0veew000001.jpg GRAPHIC 2321
5 GRAPHIC gz4ktxm0veew000004.jpg GRAPHIC 56524
  Complete submission text file 0001564590-20-023649.txt   765069
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39122 | Film No.: 20861649
SIC: 2834 Pharmaceutical Preparations